Biotage

Biotage
About Us
Change country

Follow us:
Share:
Subscribe:

About Us

About BiotageBiotage is a Global Impact Tech Company committed to solving society’s problems. We offer workflow solutions and products to customers in drug discovery and development, analytical testing and water and environmental testing. Biotage is contributing to sustainable science with the goal to make the world healthier, greener and cleaner – HumanKind Unlimited. Our customers span a broad range of market segments including pharmaceutical, biotech, contract research and contract manufacturers as well as clinical, forensic and academic laboratories in addition to organizations focused on food safety, clean water and environmental sustainability. Biotage is headquartered in Uppsala in Sweden and employs 497 people worldwide. The Group had sales of 1,232 MSEK in 2021 and our products are sold in more than 80 countries. Biotage’s share (BIOT) is listed in the Large Cap segment on the NASDAQ Stockholm.Website: www.biotage.com

Pick a time period -

Tags ( Active)

All Regulatory Non-Regulatory

Biotage AB (publ) Interim report January – June 2021

Fri, Jul 16, 2021 13:00 CET

Record quarterly net salesApril–June · Net sales amounted to SEK 303.5 (254.2) million, an increase of 19.4 percent and an organic* growth of 32.1 percent. · The operating profit amounted to SEK 62.5 (24.5) million. · The operating margin was 20.6 percent (9.6). · Profit after tax amounted to SEK 46.0 (32.2) million. · Earnings per share were SEK 0.71 (0.49) before dilution and SEK 0.70 (0.49) after dilution. · Cash flow from operations increased to SEK 92.3 (57.0) million. · Net cash* as of March 31 amounted to SEK 161.1 (157.0) million. · Liquid assets

There are no items matching the current filter

There are no more items matching the current filter

Share

About Us

Biotage AB (publ) Interim report January – June 2021